• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Now accepting nominations for the Fierce Innovation Awards - Submit your application today

Actemra

drug recall FDA recall recall voluntary recall
Pharma

Fresenius Kabi launches US recall of Actemra biosimilar

Shortly after initiating a separate recall tied to mislabeled pain medicine, Fresenius Kabi is yanking a batch of another product in the U.S.
Fraiser Kansteiner Aug 12, 2026 9:13am
Johnson  Johnson

J&J nixes Tremfya trial in giant cell arteritis

Jun 25, 2024 4:45pm
Biogen

Roche, Biogen settle Actemra biosimilar lawsuit

Oct 25, 2023 10:20am
Asia

Takeda, Kyowa Kirin, Biogen—Fierce Pharma Asia

Oct 6, 2023 8:35am
Biogen

Biogen nabs FDA nod for biosimilar of Roche blockbuster Actemra

Oct 2, 2023 10:42am
Roche

Roche sues Biogen over Actemra biosimilar infringement claims

Jul 17, 2023 9:45am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings